Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 23rdDecember 2014
Summary The industry analysis specialist, has released its new report, “Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Polycystic kidney disease Therapeutics market. The report identifies the key trends shaping and driving the global Polycystic kidney disease Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Polycystic kidney disease Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-polycystic-kidney-disease-pkd-therapeutics-pipeline-assessment-andmarket-forecasts-135214 Scope The report provides information on the key drivers and challenges of the Polycystic kidney disease Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Polycystic Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
kidney disease Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Polycystic kidney disease Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Polycystic kidney disease Therapeutics market. - Analysis of key recent licensing and partnership agreements in Polycystic kidney disease Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Polycystic kidney disease Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Polycystic kidney disease Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Polycystic kidney disease Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Polycystic Kidney Disease (PKD) Therapeutics - Introduction 2.1 Disease Overview 2.2 Etiology 2.3 Pathophysiology 2.4 Risk Factors 2.5 Symptoms 2.6 Complications 2.7 Epidemiology 2.8 Diagnosis 2.8.1 Physical Examination 2.8.2 Clinical Evaluation 2.8.3 Kidney Imaging Studies 2.8.4 Genetic Tests 2.9 Treatment 2.9.1 Renal Transplantation 2.9.2 Dialysis 2.9.3 Surgery 2.9.4 Drug Therapy Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.10 GlobalData Pipeline Report Guidance 3 Polycystic Kidney Disease Therapeutics - Market Characterization 3.1 Polycystic Kidney Disease Therapeutics Market Size (2006-2011) - Global 3.2 Polycystic Kidney Disease Therapeutics Market Forecast (2011-2019) - Global 3.3 Polycystic Kidney Disease Therapeutics Market Size (2006-2011) - The US 3.4 Polycystic Kidney Disease Therapeutics Market Forecast (2011-2019) - The US 3.5 Polycystic Kidney Disease Therapeutics Market Size (2006-2011) - The UK 3.6 Polycystic Kidney Disease Therapeutics Market Forecast (2011-2019) - The UK 3.7 Polycystic Kidney Disease Therapeutics Market Size (2006-2011) - France 3.8 Polycystic Kidney Disease Therapeutics Market Forecast (2011-2019) - France 3.9 Polycystic Kidney Disease Therapeutics Market Size (2006-2011) - Germany 3.10 Polycystic Kidney Disease Therapeutics Market Forecast (2011-2019) - Germany 3.11 Polycystic Kidney Disease Therapeutics Market Size (2006-2011) - Italy 3.12 Polycystic Kidney Disease Therapeutics Market Forecast (2011-2019) - Italy 3.13 Polycystic Kidney Disease Therapeutics Market Size (2006-2011) - Spain 3.14 Polycystic Kidney Disease Therapeutics Market Forecast (2011-2019) - Spain 3.15 Polycystic Kidney Disease Therapeutics Market Size (2006-2011) - Japan 3.16 Polycystic Kidney Disease Therapeutics Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for Polycystic Kidney Disease Therapeutics Market 3.17.1 Drivers for the Polycystic Kidney Disease Therapeutics Market 3.17.2 Barrier for the Polycystic Kidney Disease Therapeutics Market 3.18 Key Events Impacting the Future Market 3.19 Opportunity and Unmet Need Analysis 3.20 Key Takeaway 4 Polycystic Kidney Disease Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed Products in the Polycystic Kidney Disease Therapeutics Market 4.3.1 Angiotensin Converting Enzyme (ACE) Inhibitors 4.3.2 Angiotensin Receptor Blockers (ARBs) 4.3.3 Beta Blockers (BBs) 4.3.4 Calcium Channel Blockers (CCBs) 4.3.5 Other Anti-Hypertensive Drugs 4.4 Key Takeaway 5 Polycystic Kidney Disease Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Polycystic Kidney Disease Therapeutics - Pipeline by Phases of Development Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.3.1 Polycystic Kidney Disease Therapeutics - Phase III Pipeline 5.3.2 Polycystic Kidney Disease Therapeutics - Phase II Pipeline 5.3.3 Polycystic Kidney Disease Therapeutics - Preclinical Pipeline 5.3.4 Polycystic Kidney Disease Therapeutics - Discovery Pipeline 5.4 Polycystic Kidney Disease Therapeutics - Pipeline by Mechanism of Action 5.5 Technology Trends Analytical Framework 5.6 Polycystic Kidney Disease Therapeutics - Promising Drugs with Novel Mechanisms of Action Under Clinical Development 5.7 Profiles of Promising Drugs Under Clinical Development 5.7.1 Afinitor (everolimus) 5.7.2 Samsca (tolvaptan) 5.8 Key Takeaway 6 Polycystic Kidney Disease Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Country 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Trial Status 6.4 Overall Sponsors 6.5 Prominent Sponsors 6.6 Top Companies Participating in Therapeutics Clinical Trials 7 Polycystic Kidney Disease Therapeutics - Strategic Assessment 7.1 Implications for Future Market Competition 8 Polycystic Kidney Disease Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Novartis AG 8.2.2 Otsuka Holdings Co., Ltd. 8.2.3 Other Companies in Polycystic Kidney Disease Therapeutics Market 9 Polycystic Kidney Disease Therapeutics - Licensing and Partnership Deals 10 Polycystic Kidney Disease Therapeutics - Appendix 10.1 Market Definitions 10.2 Abbreviations 10.3 Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
10.5 Disclaimer 10.6 Bibliography
List Of Tables Table 1: Prevalence of PKD in the Major Markets Table 2: Polycystic Kidney Disease Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 3: Polycystic Kidney Disease Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 4: Polycystic Kidney Disease Therapeutics Market, The US, Revenue ($m), 2006-2011 Table 5: Polycystic Kidney Disease Therapeutics Market, The US, Revenue ($m), 2006-2011 Table 6: Polycystic Kidney Disease Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 7: Polycystic Kidney Disease Therapeutics Market, The UK, Forecast ($m), 2011-2019 Table 8: Polycystic Kidney Disease Therapeutics Market, France, Revenue ($m), 2006-2011 Table 9: Polycystic Kidney Disease Therapeutics Market, France, Forecast ($m), 2011-2019 Table 10: Polycystic Kidney Disease Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 11: Polycystic Kidney Disease Therapeutics Market, Germany, Forecast ($m), 2011-2019 Table 12: Polycystic Kidney Disease Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 13: Polycystic Kidney Disease Therapeutics Market, Italy, Forecast ($m), 2011-2019 Table 14: Polycystic Kidney Disease Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 15: Polycystic Kidney Disease Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 16: Polycystic Kidney Disease Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 17: Polycystic Kidney Disease Therapeutics Market, Japan, Forecast ($m), 2011-2019 Table 18: Polycystic Kidney Disease Therapeutics - Phase III Pipeline Table 19: Polycystic Kidney Disease Therapeutics - Phase II Pipeline Table 20: Polycystic Kidney Disease Therapeutics - Preclinical Pipeline Table 21: Polycystic Kidney Disease Therapeutics - Discovery Pipeline Table 22: Polycystic Kidney Disease Therapeutics - Promising Drugs Under Clinical development, 2012 Table 23: Polycystic Kidney Disease Therapeutics - Clinical Trials by Country, 2012 Table 24: Polycystic Kidney Disease Therapeutics - Clinical Trials by Phase, 2012 Table 25: Polycystic Kidney Disease Therapeutics - Clinical Trials by Status, 2012 Table 26: Polycystic Kidney Disease Therapeutics - Clinical Trials by Overall Sponsors, 2012 Table 27: Polycystic Kidney Disease Therapeutics - Clinical Trials by Prominent Sponsors, 2012 Table 28: Polycystic Kidney Disease Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2012 Table 29: Novartis AG, Polycystic Kidney Disease Pipeline, 2012 Table 30: Otsuka Holdings Co., Ltd., Polycystic Kidney Disease Pipeline, 2012 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 31: Polycystic Kidney Disease Therapeutics Market - Other Future Players Table 32: Polycystic Kidney Disease Therapeutics, Licensing and Partnership Deals
List Of Figures Figure 1: Normal and Polycystic Kidney Figure 2: Polycystic Kidney Figure 3: Histology of Nephron in Normal and Polycystic Kidneys Figure 4: Tests Used for the Diagnosis of PKD Figure 5: Tests Used for the Diagnosis of Polycystic Kidney Disease (PKD) Figure 6: Revised Unified Criteria for Diagnosis of ADPKD Figure 7: Revised Unified Criteria for Diagnosis of ADPKD Figure 8: Polycystic Kidney Disease Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 9: Polycystic Kidney Disease Therapeutics, Market Share ($m), 2011 Figure 10: Polycystic Kidney Disease Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 11: Polycystic Kidney Disease Therapeutics, Market Share ($m), 2019 Figure 12: Polycystic Kidney Disease Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 13: Polycystic Kidney Disease Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 14: Polycystic Kidney Disease Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 15: Polycystic Kidney Disease Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 16: Polycystic Kidney Disease Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 17: Polycystic Kidney Disease Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 18: Polycystic Kidney Disease Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 19: Polycystic Kidney Disease Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 20: Polycystic Kidney Disease Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 21: Polycystic Kidney Disease Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 22: Polycystic Kidney Disease Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 23: Polycystic Kidney Disease Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 24: Polycystic Kidney Disease Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 25: Polycystic Kidney Disease Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 26: Polycystic Kidney Disease Therapeutics Market, Drivers and Barriers, 2012 Figure 27: Opportunity and Unmet Need in the Polycystic Kidney Disease Therapeutics Market Figure 28: Polycystic Kidney Disease Therapeutics Market - Strategic Competitor Assessment, 2012 Figure 29: Polycystic Kidney Disease Therapeutics, Pipeline by Phase of Development, 2012 Figure 30: Polycystic Kidney Disease Therapeutics - Pipeline by Mechanism of Action, 2012 Figure 31: Polycystic Kidney Disease - Technology Trends Analytics Framework, 2012 Figure 32: Polycystic Kidney Disease Therapeutics - Technology Trends Analytics Framework Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Description, 2012 Figure 33: Polycystic Kidney Disease Therapeutics - Clinical Trials by Country, 2012 Figure 34: Polycystic Kidney Disease Therapeutics - Clinical Trials by Phase, 2012 Figure 35: Polycystic Kidney Disease Therapeutics - Clinical Trials by Status, 2012 Figure 36: Polycystic Kidney Disease Therapeutics - Clinical Trials by Overall Sponsors, 2012 Figure 37: Polycystic Kidney Disease Therapeutics - Clinical Trials by Prominent Sponsors, 2012 Figure 38: Polycystic Kidney Disease Therapeutics - Top Companies Participating in Therapeutic Clinical Trials, 2012 Figure 39: Implications for Future Market Competition in Polycystic Kidney Disease Therapeutic Market, 2012 Figure 40: Polycystic Kidney Disease Therapeutics - Pipeline by Company, 2012 Figure 41: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018 Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Pulmonary Embolism (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-polycystic-kidneydisease-pkd-therapeutics-pipeline-assessment-and-market-forecasts-135214
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/